£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

Orphan Disease Oncology Therapeutics Outlook 2023-2028 US

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 26 days · 26 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 09 August 2026 15 August 2026 21 August 2026 28 August 2026
View at Amazon ↗

Price data last checked 65 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 26 days • 1 price levels

Days at Price
26 days 0 7 13 20 26 £490 Days at Price

Price Analysis

Most common price: £490 (26 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 26 days

Description

This comprehensive study provides a detailed outlook for orphan disease therapeutics in oncology across the United States from 2023 to 2028. It focuses on latent demand, also known as potential industry earnings (P.I.E.), mapped across 10,833 US zip codes. By providing specific estimates in millions of U.S. dollars for each zip code, this report offers a granular view of market opportunities. Users can access comparative benchmarks including the percent share each zip code holds relative to its state and the entire United States. This statistical approach helps professionals in sales and distribution identify high-value areas and gauge specific locations against national and state-level data. It is a specialized resource for understanding oncology market dynamics at a local level.

Key Features

Covers the 2023-2028 outlook for orphan disease therapeutics within the oncology sector.

Provides latent demand estimates in millions of U.S. dollars across 10,833 US zip codes.

Includes potential industry earnings (P.I.E.) data for precise market analysis.

Offers comparative benchmarks by reporting the percent share of each zip code relative to its state and the US.

Supports sales force and distribution planning through detailed geographic statistical data.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
27 January 2023

Similar Products You Might Like

Orphan Disease CNS Therapeutics Outlook 2023-2028 Study
99% match

Orphan Disease CNS Therapeutics Outlook 2023-2028 Study

£490.00 02 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes

£490.00 02 Oct 2026
2023-2028 US ATMP Outlook - Zip Code Demand Study
97% match

2023-2028 US ATMP Outlook - Zip Code Demand Study

£490.00 22 Aug 2026
The 2023-2028 World Outlook for Orphan Disease Therapeutics in Genetics Disorders
97% match

The 2023-2028 World Outlook for Orphan Disease Therapeutics in Genetics Disorders

£795.00 08 Sep 2026
US Targeted Therapy Liver Cancer Drug Outlook 2023-2028
96% match

US Targeted Therapy Liver Cancer Drug Outlook 2023-2028

£490.00 22 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
96% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in China

£495.00 23 Sep 2026
The 2025-2030 World Outlook for Orphan Disease Therapeutics in Genetics Disorders
96% match

The 2025-2030 World Outlook for Orphan Disease Therapeutics in Genetics Disorders

Price unavailable
US Cancer Screening Outlook 2023-2028 - Zip Code Study
96% match

US Cancer Screening Outlook 2023-2028 - Zip Code Study

£490.00 24 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan
96% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan

£495.00 02 Oct 2026
Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study
96% match

Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study

£425.00 22 Aug 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
96% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£490.00 24 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes
96% match

The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes

£490.00 01 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China

£495.00 01 Oct 2026
The 2023-2028 Outlook for Long Term Care for US Zip Codes
96% match

The 2023-2028 Outlook for Long Term Care for US Zip Codes

£490.00 30 Sep 2026
Cancer Therapies Outlook in Oceana 2016-2021 Econometric Study
96% match

Cancer Therapies Outlook in Oceana 2016-2021 Econometric Study

£425.00 25 Aug 2026
Erythropoietin Drugs US Zip Code Outlook 2023-2028 Study
96% match

Erythropoietin Drugs US Zip Code Outlook 2023-2028 Study

£490.00 03 Sep 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
96% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 21 Aug 2026
Hematology and Oncology Products Outlook in Oceana Book
96% match

Hematology and Oncology Products Outlook in Oceana Book

£425.00 21 Aug 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
96% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 27 Sep 2026
Hematology and Oncology Products in Europe Outlook 2016-2021
96% match

Hematology and Oncology Products in Europe Outlook 2016-2021

£425.00 20 Aug 2026
NSCLC Therapeutics Outlook in Asia (2013-2018) Study
96% match

NSCLC Therapeutics Outlook in Asia (2013-2018) Study

£325.00 27 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
96% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 21 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan

£495.00 26 Sep 2026
Hematology and Oncology Products in Asia Outlook Report
96% match

Hematology and Oncology Products in Asia Outlook Report

£425.00 20 Aug 2026